New analysis of Novartis’ Entresto data shows longterm benefits on heart failure readmissions and total cardiovascular deaths

Novartis International AG New analysis of Novartis' Entresto data shows longterm benefits on heart failure readmissions and total cardiovascular deaths . Processed and transmitted by N…
Read the full story: Bioportfolio Latest News